| Citation: |
ZHAO Huiduo, WU Bing, CHE Zhiying. Construction and validation of risk predictive visualized model of upper limb lymphedema after breast cancer surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 30-36. DOI: 10.7619/jcmp.20232484
|
To explore the risk factors of upper limb lymphedema after breast cancer surgery and to construct and validate a risk prediction visualized model.
A retrospective analysis was performed on the clinical data of 528 breast cancer patients who underwent surgery. The patients were randomly divided into training set(352 cases) and validation set (176 cases). The training set patients were divided into lymphedema group(67 cases) and non-lymphedema group(285 cases) based on whether they had upper limb lymphedema. Logistic regression analysis was used to screen risk factors for upper limb lymphedema after breast cancer surgery. A risk prediction visualized model was constructed and validated using R software.
The incidence of upper limb lymphedema after breast cancer surgery was 20.08% (106/528). Multivariate Logistic regression analysis showed that high body mass index (BMI), hypertension, TNM stage Ⅲ a, bilateral lesions, level Ⅲ of axillary lymph node dissection, and postoperative radiotherapy and chemotherapy were independent risk factors for upper limb lymphedema after breast cancer surgery (P < 0.05). A risk prediction nomogram model was constructed based on above six independent risk factors. The calibration curve of the model in the training set and validation set both fitted the ideal curve well; the receiver operating characteristic curve analysis showed that the area under the curve of the nomogram model in the training set and validation set for predicting upper limb lymphedema after surgery was 0.950 and 0.886, respectively; the decision curve analysis showed that the overall net benefitof the model in predicting upper limb lymphedema after surgery in the training set and validation set was higher than that of all patients receiving full intervention or no intervention.
High BMI, hypertension, stage Ⅲ a of TNM, bilateral lesions, level Ⅲ of axillary lymph node dissection, and postoperative radiotherapy and chemotherapy are independent risk factors for upper limb lymphedema after breast cancer surgery. The risk prediction nomogram model constructed based on these factors has good predictive performance.
| [1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
| [2] |
PASKETT E D, LE-RADEMACHER J, OLIVERI J M, et al. A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)[J]. Cancer, 2021, 127(2): 291-299. doi: 10.1002/cncr.33183
|
| [3] |
SIQUEIRA T C, FRÁGOAS S P, PELEGRINI A, et al. Factors associated with upper limb dysfunction in breast cancer survivors[J]. Support Care Cancer, 2021, 29(4): 1933-1940. doi: 10.1007/s00520-020-05668-7
|
| [4] |
ENGIN O, SAHIN E, SARIBAY E, et al. Risk factors for developing upper limb cellulitis after breast cancer treatment[J]. Lymphology, 2022, 55(2): 77-83.
|
| [5] |
朱婷, 周海兰, 华骁帆. 基于多维度指标预测乳腺癌术后复发的列线图模型建立及应用[J]. 实用临床医药杂志, 2023, 27(5): 43-48. doi: 10.7619/jcmp.20221838
|
| [6] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J]. 中国癌症杂志, 2017, 27(9): 695-759.
|
| [7] |
CZERNIEC S A, WARD L C, REFSHAUGE K M, et al. Assessment of breast cancer-related arm lymphedema: comparison of physical measurement methods and self-report[J]. Cancer Invest, 2010, 28(1): 54-62. doi: 10.3109/07357900902918494
|
| [8] |
MARCHICA P, D'ARPA S, MAGNO S, et al. Integrated treatment of breast cancer-related lymphedema: a descriptive review of the state of the art[J]. Anticancer Res, 2021, 41(7): 3233-3246. doi: 10.21873/anticanres.15109
|
| [9] |
BIANCHI A, SALGARELLO M, HAYASHI A, et al. Breast cancer related upper limb lymphedema: approach and surgical management[J]. Minerva Surg, 2021, 76(6): 575-579.
|
| [10] |
HARA Y, OTSUBO R, SHINOHARA S, et al. Lymphedema after axillary lymph node dissection in breast cancer: prevalence and risk factors-a single-center retrospective study[J]. Lymphat Res Biol, 2022, 20(6): 600-606. doi: 10.1089/lrb.2021.0033
|
| [11] |
SHEN A M, LU Q, FU X, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies[J]. Support Care Cancer, 2022, 31(1): 18.
|
| [12] |
BRUNELLE C L, ROBERTS S A, HORICK N K, et al. Integrating symptoms into the diagnostic criteria for breast cancer-related lymphedema: applying results from a prospective surveillance program[J]. Phys Ther, 2020, 100(12): 2186-2197. doi: 10.1093/ptj/pzaa162
|
| [13] |
KALEMIKERAKIS I, EVAGGELAKOU A, KAVGA A, et al. Diagnosis, treatment and quality of life in patients with cancer-related lymphedema[J]. J BUON, 2021, 26(5): 1735-1741.
|
| [14] |
饶坤林, 陈健健. 乳腺癌患者术后发生上肢淋巴水肿的危险因素分析[J]. 中国临床医生杂志, 2021, 49(9): 1083-1085.
|
| [15] |
YUSOF K M, AVERY-KIEJDA K A, AHMAD SUHAIMI S, et al. Assessment of potential risk factors and skin ultrasound presentation associated with breast cancer-related lymphedema in long-term breast cancer survivors[J]. Diagnostics, 2021, 11(8): 1303. doi: 10.3390/diagnostics11081303
|
| [16] |
NOGUCHI M, INOKUCHI M, NOGUCHI M, et al. Axillary surgery for breast cancer: past, present, and future[J]. Breast Cancer, 2021, 28(1): 9-15. doi: 10.1007/s12282-020-01120-0
|
| [17] |
AOISHI Y, OURA S, NISHIGUCHI H, et al. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration[J]. Breast Cancer, 2020, 27(5): 929-937. doi: 10.1007/s12282-020-01088-x
|
| [18] |
BYUN H K, CHANG J S, IM S H, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective[J]. Ann Surg, 2021, 274(1): 170-178. doi: 10.1097/SLA.0000000000003491
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: